SUGAMMADEX MSN (Accelagen Pty Ltd)
Product name
SUGAMMADEX MSN
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
95 (255 working days)
Active ingredients
sugammadex sodium
Registration type
New generic medicine
Indication
SUGAMMADEX MSN (solution for injection) is indicated for reversal of neuromuscular blockade induced by rocuronium or vecuronium in patients 2 years of age and older.